Phase 1-2 Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Various Combinations of BGB--A425 and LBL-007 with Tislelizumab in Patients with Advanced Solid Tumors (CTMS# 21-0064)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Daruka Mahadevan, MD, PhD

For more information about this study

View Details